Id3 induces a caspase-3- and -9-dependent apoptosis and mediates UVB sensitization of HPV16 E6/7 immortalized human keratinocytes

Oncogene

Volumn 25, Issue 26, 2006, Pages 3649-3660

  Simbulan Rosenthal, C M ^a   Daher, A ^a   Trabosh, V ^a   Chen, W C ^a   Gerstel, D ^a   Soeda, E ^a   Rosenthal, D S ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspases; Id proteins; Immortalization

Indexed keywords

CASPASE 3; CASPASE 9; INHIBITOR OF DIFFERENTIATION 3; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL 2; PROTEIN E6; PROTEIN E7; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; FRAGMENTATION REACTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROCESSING; RADIATION CARCINOGENESIS; TRANSCRIPTION REGULATION; ULTRAVIOLET B RADIATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 9; CASPASES; CELL LINE, TRANSFORMED; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; KERATINOCYTES; MICROSCOPY, FLUORESCENCE; NEOPLASM PROTEINS; ONCOGENE PROTEINS, VIRAL; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; ULTRAVIOLET RAYS;

EID: 33745523029     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209407     Document Type: Article

References (40)

1. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA, Munger K. (1999). Proc Natl Acad Sci USA 96: 9637-9641.
2. Atchley WR, Fitch WM. (1997). Proc Natl Acad Sci USA 94: 5172-5176.
3. Backvall H, Asplund A, Gustafsson A, Sivertsson A, Lundeberg J, Ponten F. (2005). Mutat Res 571: 65-79.
4. Casciola-Rosen L, Nicholson D, Chong T, Rowan K, Thornberry N, Miller D et al. (1996). J Exp Med 183: 1957-1964.
5. Cleaver JE, Crowley E. (2002). Front Biosci 7: d1024-d1043.
6. Daher A, Simbulan-Rosenthal CM, Rosenthal DS. (2006). Exp Dermatol 15: 23-34.
7. Decraene D, Van Laethem A, Agostinis P, De Peuter L, Degreef H, Bouillon R et al. (2004). J Invest Dermatol 123: 207-212.
8. Fearnhead HO, Rodriguez J, Govek EE, Guo W, Kobayashi R, Hannon G et al. (1998). Proc Natl Acad Sci USA 95: 13664-13669.
9. Florio M, Hernandez MC, Yang H, Shu HK, Cleveland JL, Israel MA. (1998). Mol Cell Biol 18: 5435-5444.
10. Frost C, Williams G, Green A. (2000). J Invest Dermatol 115: 273-277.
11. Harvey I, Frankel S, Marks R, Shalom D, Nolan-Farrell M. (1996). Br J Cancer 74: 1302-1307.
12. Heisler GM, Grant RH, Gao W, Slusser JR. (2004). Photochem Photobiol 80: 422-428.
13. Iavarone A, Garg P, Lasorella A, Hsu J, Israel MA. (1994). Genes Dev 8: 1270-1284.
14. Kee BL, Rivera RR, Murre C. (2001). Nat Immunol 2: 242-247.
15. Koyama T, Suzuki H, Imakiire A, Yanase N, Hata K, Mizuguchi J. (2004). Anticancer Res 24: 1519-1524.
16. Lasorella A, Iavarone A, Israel MA. (1996). Mol Cell Biol 16: 2570-2578.
17. Liu J, Shi W, Warburton D. (2000). Biochem Biophys Res Commun 273: 1042-1047.
18. Marks R, Foley P, Goodman G, Hage BH, Selwood TS. (1986). Br J Dermatol 115: 649-655.
19. Marks R, Rennie G, Selwood TS. (1988). Lancet 1: 795-797.
20. Massari ME, Murre C. (2000). Mol Cell Biol 20: 429-440.
21. Mitchell KO, Ricci MS, Miyashita T, Dicker DT, Jin Z, Reed JC et al. (2000). Cancer Res 60: 6318-6325.
22. Miyashita T, Reed JC. (1995). Cell 80: 293-299.
23. Mueller C, Baudler S, Welzel H, Bohm M, Nickenig G. (2002). Circulation 105: 2423-2428.
24. Murre C, Bain G, van Dijk MA, Engel I, Furnari BA, Massari ME et al. (1994). Biochim Biophys Acta 1218: 129-135.
25. Murre C, McCaw PS, Baltimore D. (1989a). Cell 56: 777-783.
26. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN et al. (1989b). Cell 58: 537-544.
27. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M et al. (1995). Nature 376: 37-43.
28. Nickoloff BJ, Chaturvedi V, Bacon P, Qin JZ, Denning MF, Diaz MO. (2000). J Biol Chem 275: 27501-27504.
29. Norton JD, Atherton GT. (1998). Mol Cell Biol 18: 2371-2381.
30. Norton JD. (2000). J Cell Sci 113: 3897-3905.
31. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y et al. (2001). Nature 409: 1067-1070.
32. Park HR, Min SK, Cho HD, Kim KH, Shin HS, Park YE. (2004). J Cutan Pathol 31: 544-549.
33. Shiloh Y. (2003). Nat Rev Cancer 3: 155-168.
34. Simbulan-Rosenthal CM, Trabosh V, Velarde A, Chou FP, Daher A, Tenzin F et al. (2005). Oncogene 4: 5443-5458.
35. Simbulan-Rosenthal CM, Velena A, Veldman T, Schlegel R, Rosenthal DS. (2002). J Biol Chem 277: 24709-24716.
36. Song Q, Lees-Miller S, Kumar S, Zhang Z, Chan D, Smith G et al. (1996). EMBO J 15: 3238-3246.
37. Stratton SP. (2001). Curr Oncol Rep 3: 295-300.
38. Takehara T, Takahashi H. (2003). Cancer Res 63: 3054-3057.
39. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR et al. (1995). Cell 81: 801-809.
40. Van Laethem A, Van Kelst S, Lippens S, Declercq W, Vandenabeele P, Janssens S et al. (2004). FASEB J 18: 1946-1948. Epub 2004 Sep 23.